Hester Bio gets a 'jab'

about 4 months ago
No Image

Hester Biosciences is up and bright in the news. Figuring among the top five gainers on the BSE, the stock which had closed on Friday at Rs.2470, opened over 6% higher and went on to hit a new 52-week high at Rs.2944, up over 19%.

The stock is up on news that the company has tied up with the Gujarat Govt to explore the option of producing Covaxin, the vaccine of Bharat Biotech, through a technology transfer.

This is through a triparty agreement - Gujarat Biotechnology Research Centre, Department of Science and Technology Govt of Gujarat along with Hester Biosciences and OmniBRx.

The idea is to produce a minimum 20 million doses per month. Given the acute shortage of vaccines in the country, this is a good option as Hester already has vaccine making facilities.

The company is an animal and poultry vaccines manufacturer, with plants situated in Gujarat and Nepal. It currently has a 30% share of the poultry vaccines market in the country.

Articles you may also like

Popular Comments

No comment posted for this article.